Saroja Pharma Industries India (NSE:SAROJA) GF Score: 15/100 (As of Sep. 01, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAROJA Saroja Pharma Industries India Ltd NSE:SAROJA
15 GF Score
Price ₹40.95
! 4 Warning Signs
View Full Analysis

What is Saroja Pharma Industries India GF Score?

Saroja Pharma Industries India NSE:SAROJA +3.15% 15 GF Score is 15 as of Sep. 01, 2026, which is 6% below its 10-year median of 16.00. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Saroja Pharma Industries India has the GF Score of 15, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 5/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Saroja Pharma Industries India might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Saroja Pharma Industries India  (NSE:SAROJA) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Saroja Pharma Industries India GF Score Related Terms

NSE:SAROJA vs ZTS: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saroja Pharma Industries India GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's GF Score distribution charts can be found below:

* The bar in red indicates where Saroja Pharma Industries India's GF Score falls into.


NSE:SAROJA
15GF Score
Saroja Pharma Industries India Ltd NSE:SAROJA
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 15 mean?
Saroja Pharma Industries India (NSE:SAROJA) has a GF Score of 15 as of Sep. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Saroja Pharma Industries India and its competitors. This is near median its historical median of 16.00. Over the past decade, Saroja Pharma Industries India's GF Score has ranged from 12.00 to 23.00.
Is Saroja Pharma Industries India's GF Score too high?
Saroja Pharma Industries India's current GF Score of 15 is near median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 12.00 to a high of 23.00. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's GF Score compare to ZTS?
Saroja Pharma Industries India's GF Score of 15 can be compared against companies in the Drug Manufacturers industry. Historically, Saroja Pharma Industries India's own GF Score has ranged from 12.00 to 23.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Saroja Pharma Industries India and its competitors. Saroja Pharma Industries India's current GF Score is 15, which is near median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current GF Score of 15. The current GF Score is 15, which is near median its 10-year median of 16.00. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current GF Score is 15 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Saroja Pharma Industries India Business Description

Address Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score

Get the complete analysis for NSE:SAROJA

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.95
Price